BanderasNews
Puerto Vallarta Weather Report
Welcome to Puerto Vallarta's liveliest website!
Contact UsSearch
Why Vallarta?Vallarta WeddingsRestaurantsWeatherPhoto GalleriesToday's EventsMaps
 NEWS/HOME
 AROUND THE BAY
 AROUND THE REPUBLIC
 AROUND THE AMERICAS
 THE BIG PICTURE
 BUSINESS NEWS
 TECHNOLOGY NEWS
 WEIRD NEWS
 EDITORIALS
 ENTERTAINMENT
 VALLARTA LIVING
 TRAVEL / OUTDOORS
 HEALTH / BEAUTY
 SPORTS
 DAZED & CONFUSED
 PHOTOGRAPHY
 CLASSIFIEDS
 READERS CORNER
 BANDERAS NEWS TEAM
Sign up NOW!

Free Newsletter!
Puerto Vallarta News NetworkNews from Around the Americas | June 2005 

Canada Is Drafting Regulations to Curb Bulk Drug Exports to U.S.
email this pageprint this pageemail usClifford Krauss - NYTimes


Mexican Mafia tattoo
(Photo: Security Threat Group)
Toronto - The government announced Wednesday that it was drafting legislation to limit bulk exports of essential Canadian drugs in an effort to ensure that online pharmacy sales to the United States do not cause domestic shortages. But the proposal fell far short of what the online pharmacy industry feared might have forced it to leave Canada.

It is unlikely that the two million uninsured and underinsured Americans who depend on cheaper Canadian drugs to treat chronic conditions will be immediately affected. It is possible, however, that tighter regulations in Canada may give other foreign online suppliers a new competitive edge and encourage Canadian companies to warehouse more of their inventories in other countries.

"Canada cannot be the drugstore of the United States of America," Health Minister Ujjal Dosanjh told reporters as he announced the legislation and several vaguely defined proposed regulatory changes, including one that could limit some Canadian doctors' practice of co-signing online prescriptions for American patients without examining them.

"We have to make sure that we protect the safety and supply of the drugs for Canadians," Mr. Dosanjh said, "and also the safety of the consumers of these prescriptions."

He said new regulations were needed because he expected the United States Congress to pass legislation that would allow large imports of prescription drugs.

Online drug sales from Canada to the United States have reached more than $800 million a year, about triple the total of five years ago, although sales have begun to plateau because of price increases linked to the rising value of the Canadian dollar.

The practice has become a thorn in the side of American drug companies, which have increasingly limited sales to Canadian pharmacists who undercut them in American markets. It has also raised concerns among Canadian officials that the exports could eventually reduce supplies and raise prices for Canadians, which would hurt the budgets of provincial governments that finance purchases of prescription drugs.

Since late last year, Mr. Dosanjh has periodically voiced sharp criticisms of the Canadian online pharmaceutical industry. Many of the largest online pharmacies began placing their inventories overseas and forming partnerships with pharmaceutical companies in Britain, Australia and New Zealand.

But after disagreements among leaders in the governing Liberal party over the risk of destroying an industry that employs 5,000 Canadians, Mr. Dosanjh appeared willing on Wednesday to negotiate on regulations the industry might be able to live with.

"My intention is not to kill the industry," he said Wednesday.

Industry officials said they welcomed Mr. Dosanjh's proposal to ban bulk exports of drugs to institutions like health maintenance organizations anytime a shortage arises in Canada. It's unlikely any changes would be enacted before a national election, expected early next year.

"We have to hope for the best and prepare for the worst," said Paul Turner, director of sales and marketing at Universal Drugstore, a large online pharmacy based in Winnipeg. The greatest danger in Mr. Dosanjh's proposals, as industry officials see it, was his opposition to the current practice of Canadian doctors co-signing American customers' prescriptions. The co-signing doctor is required by Canadian law to review the American doctor's diagnosis and prescribed treatment, but does not actually see the patient.

Mr. Dosanjh appeared to leave open the possibility of a compromise, saying he wanted to seek solutions with the industry and regulators.



In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving
the included information for research and educational purposes • m3 © 2008 BanderasNews ® all rights reserved • carpe aestus